Q-Linea

Report Publication Announcement • Apr 24, 2023

Changed date for the annual general meeting

The board of Q-linea AB (publ) ("Q-linea" or the "Company") has decided to change the date of the annual general meeting.

The background to the board's decision is the cost-saving process that was initiated and announced via a separate press release, meaning that the board found it most appropriate to postpone the annual general meeting. Q-linea's 2023 Annual General Meeting will be held at 4:00 p.m., Tuesday, June 13, 2023. The meeting will be held at Hubben Konferens, Uppsala Science Park room 3+4, Dag Hammarskjölds väg 38 in Uppsala.

The notice to the annual general meeting will be distributed through a press release.

For more information, please contact:

Jonas Jarvius, CEO, Q-linea AB Jonas.Jarvius@qlinea.com +46 (0) 70-323 77 60

Anders Lundin, CFO, Q-linea AB Anders.Lundin@qlinea.com +46 (0) 70-600 15 20

About Q-linea

Q-linea is an innovative infection diagnostics company that primarily develops instruments and disposables for rapid and reliable infection diagnostics. Our vision is to help save lives by ensuring antibiotics continue to be an effective treatment for future generations. Q-linea develops and delivers preferred solutions for healthcare providers, enabling them to accurately diagnose and treat infectious disease in the shortest possible time. The company's lead product ASTar® is a fully automated instrument for antibiotic susceptibility testing (AST), giving a susceptibility profile within six hours directly from a positive blood culture. For more information, please visit www.qlinea.com.

Attachments

Changed date for the annual general meeting